Pubblicazioni

2009

L. Pazzaglia, A. Chiechi, A. Conti, G. Gamberi, G. Magagnali, L. Moranti, P. Picci, M. Mercuri, M.S. Benassi: Genetic and molecular alterations in rhabdomyosarcoma: mRNA overexpression pf MCL1 and MAP2K4 genes. Histol. Histopathol. Epub 2008, 24: 61-67, 2009 IF: 2,007

S. Savola, A. Klami, A. Tripathi, T. Niini, M. Serra, P. Picci, S. Kaski, D. Zambelli, K. Scotlandi, S. Knuutila: Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors. BMC Cancer, epub 2009. IF: 2,709

S. Ferrari, A. Brach del Prever, E. Palmerini, E. Staals, M. Berta, A. Balladelli, P. Picci, F. Fagioli, G. Bacci, D. Vanel: Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcoma. Pediatr. Blood Cancer, epub, 2009 IF: 2,164

M. Azura, D. Vanel, M. Alberghini, P. Picci, E. Staals, M. Mercuri: Parosteal osteosarcoma dedifferentiating into telangiectatic osteosarcoma: importance of lytyc changes and fluid cavities at imaging. Skeletal Radiology Epub, 2009. IF: 1,136

K. Scotlandi, D. Remondini, G. Castellani, MC Manara, F. Nardi, L. Cantiani, M. Francescani, M. Mercuri, AM Caccuri, M. Serra, S. Knuutila, P. Picci: Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome. J Clin Oncol, 2009 epub IF: 15,484

G. Toffoli, P. Biason, A. Russo, E. De Mattia, E. Cecchin, C. Hattinger, M. Pasello, M. Alberghini, C. Ferrari, K. Scotlandi, P. Picci, M. Serra: Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high grade osteosarcoma development and survival. Clin Cancer Res 15: 3550-3556 begin_of_the_skype_highlighting              3550-3556      end_of_the_skype_highlighting, 2009 IF: 6,250

E. Palmerini, E.L. Staals, M. Alberghino, L. Zanella, C. Ferrari, M.S. Benassi, P. Picci, M. Mercuri, G. Bacci, S. Ferrari: Synovial sarcoma: retrospective analysis of 250 patients treated at a single institution. Cancer epub, 2009 IF: 4,632

E.E. Zamora, A. Mansor, D. Vanel, C. Errani, M. Mercuri, P. Picci, M. Alberghini: Synovial condrosarcoma: Report of two cases and literature review. Eur. J. Radiol. Epub, 2009. IF: 1,915

D. Zambelli, M. Zuntini, F. Nardi, M.C. Manara, M. Serra, L. Landuzzi, P.L. Lollini, S. Ferrari, M. Alberghini, A. Llombart-Bosch, E. Piccolo, S. Iacobelli, P. Picci, K. Scotlandi: Biological indicators of prognosis in Ewing’s sarcoma: an emerging role for lectin galactoside-binding solubile 3 binding protein (LGALS3BP). Int. J. Cancer, epub 2009 IF: 4,555

B. Perbal, N. Lazar, D. Zambelli, J.A Lopez-Guerrero, A. Llombart-Bosch, K. Scotlandi, P. Picci: Prognostic relevance of CCN3 in Ewing sarcoma. Hum. Pathol. Epub, 2009 IF: 3,034

M.A. Pantaleo, L. Landuzzi, G. Nicoletti, C. Nanni, S. Boschi, G. Piazzi, D. Santini, M. Di Battista, P. Castellucci, F. Lodi, S. Fanti, P.-L. Lollini, G. Biasco: Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model. Clin. Exp. Med. 9: 199-205, 2009 IF: 1,531

L. Menotti, G. Nicoletti, V. Gatta, S. Croci, L. Landuzzi, C. De Giovanni, P. Nanni, P.-L. Lollini, G. Campadelli-Fiume: Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. Proc. Natl. Acad. Sci. 106: 9045-9050, 2009. IF: 9,598

M. Serra, K. Scotlandi: Caveolins in the development and diseases of musculoskeletal system. Cancer Lett. 284: 113-121, 2009 IF: 3,398

M.A. Pantaleo, M. Nannini, A. Maleddu, S. Fanti, C. Nanni, S. Boschi, F. Lodi, G. Nicoletti, L. Landuzzi, P.L. Lollini, G. Biasco: Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer. Ann. Oncol. 20: 213-216, 2009. IF 4,875

C. De Giovanni, G. Nicoletti, L. Landuzzi, S. Croci, A. Palladini, A. Antognoli, A. Murgo, M.L. Ianzano, V. Grosso, V. Stivani, M. Iezzi, P. Musiani, P. Nanni, P.L. Lollini: Tamoxifen combined to anti-HER-2/neu cell vaccine does not camper cancer immunopreventive efficacy. Vaccine 27: 2065-2069, 2009. IF: 3,377

P. Nanni, G. Nicoletti, A. Palladini, A. Astolfi, P. Ribella, S. Croci, L. Landuzzi, G. Monduzzi, V. Stivani, A. Antognoli, A. Murgo, M. Ianzano, C. De Giovanni, P.L. Lollini: Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. Mol. Cancer Ther. 8: 754-761, 2009. IF: 4,800

L. Moskovsky, K. Szuhai, T. Krenacs, P.C. Hogendoorn, M. Szendroi, M.S. Benassi, L. Kopper, T. Fule, Z. Sapi: Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis. Genes Chromosomes Cancer, epub, 2009. IF: 4,532

M.A. Pantaleo, L. Landuzzi, G. Nicoletti, C. Nanni, S. Boschi, G. Piazzi, D. Santini, M. Di Battista, P. Castellucci, F. Lodi, S. Fanti, P.L. Lollini, G. Biasco: Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastronitestinal stromal tumors model. Clin. Exp. Med. 2009, Epub. IF: 1,531

C. De Giovanni, G. Nicoletti, A. Paladini, S. Croci, L. Landuzzi, A. Antognoli, A. Murgo, A. Astolfi, S. Ferrini, M. Fabbi, AM Orengo, A. Amici, M.L. Penichet, L. Aurisicchio, M. Iezzi, P. Musiani, P. Nanni, P.L. Lollini: A-multi-DNA preventive vaccine for p53/Neu driver cancer sindrome. Hum. Gen. Ther. 2009, Epub. IF: 4,330

G. Bacci, S. Boriani, A. Balladelli, E. Barbieri, A. Longhi, M. Alberghini, K. Scotlandi, C. Forni, P. Pollastri, D. Vanel, M. Mercuri: Treatment of non-metastatic Ewing’s sarcoma family tumors of the spine and sacrum: the experience from a single institution. Eur. Spine J. , 2009, Epub IF: 2,021

A. Bremond, O. Meynet, K. Mahiddine, S. Coito, M. Tichet, K. Scotlandi, J.P. Breittmayer, P. Gounon, P.A. Gleeson, A. Bernard, G. Bernard: Regulation of HLA class I surface expression requires CD99 and p230/golgin-245 interaction. Blood. 113(2):347-57, 2009 I.F. 10,896

2008

B. Perbal, M. Zuntini, D. Zambelli, M. Serra, M. Sciandra, L. Cantiani, E. Lucarelli, P. Picci, K. Scotlandi: Prognostic value of CCN3 in osteosarcoma. Clin. Cancer Res. 14: 701-709, 2008 IF: 6,250

I. Scionti, M. Pasello, F. Michelacci, C.M. Hattinger, G. Stoico, G. Bacci, S. Ferrari, K. Scotlandi, P. Picci, M. Serra: Clinical impact of methotrexate resistance-associated genes C-myc and Dihydrofolate reductase in high grade osteosarcoma. Ann. Oncol. 19: 1500-1508, 2008 IF: 4,875

P.G. Casali, Jost L., Reichardt P., Schlemmer M., Blay J.Y, ESMO Guidelines Working Group: Gastrintestinal stromal tumors: ESMO recommendations for diagnosis, treatment and follow.up Ann. Oncol. 19: 35-38, 2008 IF: 4,875

P.G. Casali, Jost L., S. Sleijfer, J. Verveij, Blay J.Y, ESMO Guidelines Working Group: Soft tissue sarcomas: ESMO recommendations for diagnosis, treatment and follow.up. Ann. Oncol. 19: 89-93, 2008 IF: 4,875

K. Scotlandi, P. Picci: Targeting insulin-like growth factor 1 receptor in sarcomas. Curr. Opin. Oncol. 20: 419-427, 2008. IF: 3,692

MS Benassi. L. Pazzaglia, A. Chiechi, M. Alberghini, A. Conti, S. Cattaruzza, B. Wasserman, P. Picci, R. Perris: NG2 expression predicts the metastasis formation in soft tissue sarcoma patients. J. Orthop. Res., epub, 2008. IF: 2,437

M. Pasello, F. Michelacci, I. Scionti, C. Hattinger, M. Zuntini, AM Caccuri, K. Scotlandi, P. Picci, M. Serra: Overcoming glutathione-S-transferase P1-related cisplatin resistance in osteosarcoma. Cancer Res. 15: 68: 6661-6668, 2008. IF: 7,672

A. Pession, E. Dama, R. Rondelli, C. Magnani, M. De Rosa, F. Locatelli, F. Fagioli, R. Haupt, M. Jankovic, B. Terracini, F. Merletti, G. Pastore, Italian Association of Paedriatic Haematology and Oncology, with 46 collaborators (including P. Picci): Survival of children with cancer in Italy, 1989-1998. A report from the hospital based registry of the Italian Association of Paedriatic Haematology and Oncology (AIEOP) Eur. J. Cancer 44: 1282-1289, 2008 IF: 4,454

E. Dama, R. Rondelli, M. De Rosa, M. Aricò, M. Carli, F. Fossati-Bellani, C. Magnani, F. Merletti, G. Pastore, A. Pession, Italian Association of Paedriatic Haematology and Oncology, with 59 collaborators (including P. Picci): Patterns of domestic migrations and access to childhood cancer care centres in Italy: A report from the hospital based registry of the Italian Association of Paedriatic Haematology and Oncology (AIEOP). Eur. J. Cancer 44: 2101-2105, 2008 IF: 4,454

G. Bacci, A. Balladelli, E. Palmerini, M. Alberghini, P. Pollastri, S. Galletti, M. Mercuri, P. Picci: Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients. The Rizzoli Institute experience. J. Pediatr. Hematol. Oncol. 30: 908-912, 2008 IF: 1,17

C.M. Hattinger, G. Stoico, F. Michelacci, M. Pasello, I. Scionti, D. Remondini, G.C. Castellani, M. Fanelli, K. Scotlandi, P. Picci, M. Serra: Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines. Genes Chromosomes Cancer epub 2008 IF: 4,532

C. Capanni, R. Del Coco, S. Squarzoni, M. Columbaro, E. Mattioli, D. Camozzi, A. Rocchi, K. Scotlandi, N. Maraldi, R. Foisner, G. Lattanzi: Prelamin A is involved in early steps of muscle differentiation. Exp Cell Res. Epub, 2008. IF: 3,695

E. Zuffa, M. Mancini, G. Brusa, E. Pagnotta, C.M. Hattinger, M. Serra, D. Remondini, G. Castellani, P. Corrado, E. Barbieri, M.A. Cantucci: P53 oncosuppresssor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2 Int J Radiat Biol 84: 591-601, 2008 IF: 1,468

M.A. Pantaleo, M. Nannini, A. Maleddu, S. Fanti, C. Nanni, S. Boschi, F. Lodi, G. Nicoletti, L. Landuzzi, P.L. Lollini, G. Biasco: Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer. Ann. Oncol. Epub, 2008 IF: 4,875

C. Zucchini, A. Rocchi, M.C. Manara, P. De Sanctis, C. Capanni, M. Bianchini, K. Scotlandi, L. Valvassori: Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines. Int. J. Oncol. 32: 17-31, 2008 IF: 2,2295

A.C. Berardi, S. Marsilio, C. Rofani, O. Salvucci, P. Altavista, F.M. Perla, F. Diomedi-Camassei, S. Uccini, G. Kokai, L. Landuzzi, H.P. McDowell, C. Dominici: Up-regulation of EphB and Ephrin-B expression in rhabdomyosarcoma. Anticancer Res. 28: 763-770, 2008 IF: 1,414

2007

G. Bacci, A. Balladelli, C. Forni, S. Ferrari, A. Longhi, P. Bacchini, M. Alberghini, N. Fabbri, M.S. Benassi, A. Briccoli, P. Picci: Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years. Cancer, 2007, epub IF: 4,582

R. Luksch, G. Grignani, F. Fagioli, A. Brach del Prever, M. Podda, S. Aliberti, M. Casanova, A. Prete, G. Hanau, A. Tamburini, P. Allione, A. Tienghi, S. Ferrari, P. Collini, A. Marchiano, L. Gandola, M. Aglietta, E. Madon, P. Picci, F. Fossati-Bellani: Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing’s family tumours. Eur. J. Cancer, 2007 epub IF: 4,167

P. Picci: Osteosarcoma (Osteogenic sarcoma). Orphanet J. Rare Dis. 23: 2-6. IF : NO

M.C. Manara, Landuzzi L., Nanni P., Nicoletti G., Zimbelli D., Lollini P.L., Nanni C., Hofmann F., Garcia-Echevarria C. Picci P., Scotlandi K.: Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma. Clin. Cancer Res. 13: 1322-1330, 2007. IF 6,177

K. Scotlandi, M. Puntini, M.C. Manara, M. Sciandra, A. Rocchi, S. Benini, G. Nicoletti, G. Bernard, P. Nanni, P.L. Lollini, A. Bernard, P. Picci: CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressine c-Src kinase activity. Oncogene, 2007 epud IF: 6,582

M.S. Benassi, F. Ponticelli, E. Azioni, G. Gamberi, L. Pazzaglia, A. Chiechi, A. Conti, P. Spessotto, M. Scapolan, E. Pienotti, P. Bacchini, P. Picci: Histol. Histopathol, 22: 1017-1024, 2007 I.F.: 2,182

G. Bacci, C. Forni, A. Longhi, S. Ferrari, M. Mercuri, F. Bertoni, M. Serra, A. Briccoli, A. Balladelli, P. Picci: Local recurrence and local control of non-metastatic osteosarcoma of the extremities: A 27 year experience in a single institution. J. Surg. Oncol 96: 118-123, 2007 IF: 2,183

S. Ferrari, F. Bertoni, E. Palmerini, C. Errani, P. Bacchini, E. Pienotti, M. Mercuri, A. Longhi, M. Cesari, P. Picci: Predictive factors of histologic response to primary chemotherapy in patients with Ewing Sarcoma. J. Pediatr. Hematol. Oncol. 29: 364-368, 2007 IF: 1,170

G. Bacci, S. Ferrari, M. Mercuri, A. Longhi, N. Fabbri, S. Galletti, C. Forni, A. Balladelli, M. Serra, P. Picci: Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years. Acta Orthop. 78: 377-384, 2007 IF: 1,305

L. Cantiani, M.C. Manara, C. Zucchini, P. De Sanctis, M. Puntini, L. Valvassori, M. Serra, M. Olivero, M.F. Di Renzo, M.P. Colombo, P. Picci, K. Scotlandi: Caveolin-1 reduces osteosarcoma metastases by inibiting c-Src activity and Met signalling. Cancer Res. 67: 7675-7685 IF: 7, 656

G. Bacci, A. Balladelli, C. Forni, A. Longhi, M. Serra, N. Fabbri, M. Alberghini, S. Ferrari, M.S. Benassi, P. Picci: Ewing’s sarcoma family tumours: Differences in clinicopathological characteristics at presentation berween localised and metastatic tumours. J. Bone Joint Surg. (Br) 89: 1229-1233, 2007 IF: 1,79

M. Serra, P. Picci, S. Ferrari, P. Picci: Prognostic value of p-glycoprotein in high-grade osteosarcoma. J. Clin. Oncol. 35: 4558-4862, 2007. IF: 13,598

G. Bacci, A. Balladelli, C. Forni, S. Ferrari, A. Longhi, M.S. Benassi, A. Briccoli, M. Serra, P. Picci: Adjuvant and neoadjuvant chemotherapy for ewing’s sarcoma family tumors and osteosarcoma of the extremity: further outcome for patients event-free survivors 5 years from the beginning of treatment. Ann. Oncol. Epud, 2007 IF: 5,179

S. Savola, F. Nardi, K. Scotlandi, P. Picci, S. Knuutila: Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcoma. Cytogenet. Genome Res. 119: 21-26, 2007 IF: 1,993

G. Brusa, E. Zuffa, C.M. Hattinger, M. Serra, D. remondini, G. Castellani, S. Righi, C. Campielli, S. Pileri, P.L. Zinzani, A. Gabriele, M. Mancini, P. Corrado, E. Barbieri, M.A. Cantucci: Genomic imbalances associated with secondary acute leukemias in Hodgkin Lymphoma. Oncol. Rep. 18: 1427-1434, 2007 . IF: 1,567

C. De Giovanni, S. Croci, G. Nicoletti, L. Landuzzi, A. Paladini, T. Pannellini, L. Borgia, M. Iezzi, E. Di Carlo, A.M. Orengo, R.C. Kennedy, P.L. Lollini, P. Nanni, P. Musini: Inhibition of prostate carcinogenesis by combined active immunoprophylaxis. Int. J. Cancer 121: 88-94, 2007 I.F.: 4,693

A.M. Bleau, N. Planque, N. Lazar, D. Zambelli, A. Ori, T. Quan, G. Fisher, K. Scotlandi, B. Perbal : Antiproliferative activity of CCN3: Involvement of the C-terminal module and post-translational regulation. J. Cell Biochem, 101: 1475-1491, 2007 I.F.: 5,808

Dalmizrak O, Wu A, Chen J, Sun H, Utama FE, Zambelli D, Tran TH, Rui H,
Baserga R: "Insulin receptor substrate-1 regulates the transformed phenotype
of BT-20 human mammary cancer cells". Cancer Res. 2007 Mar 1; 67(5):2124-30 IF: 7,656

S. Croci, G. Nicoletti, L. Landuzzi, A. Palladini, F. Chiarini, P. Nanni, P.-L. Lollini & Carla De Giovanni: Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells. Oncol Rep., 18: 451-456, 2007. IF: 1,567

S. Croci, L. Landuzzi, G. Nicoletti, A. Palladini, A. Antognoli, C. De Giovanni, P. Nanni & P.-L. Lollini: Expression of Connective Tissue Growth Factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis. Pathol. Oncol. Res. 13: 336-339, 2007 IF 1,475
.
S. Ehlers, T. Mueck, S. Adams, L. Landuzzi, P.-L. Lollini, B. Munz: Rip2 regulates growth and differentiation of normal myoblasts and of rhadomyosarcoma cells. Eur. J. Cell Biol. epub, 2007. 87: 163-172,2008 IF 3,224

P. Nanni, G. Nicoletti, A. Palladini, S. Croci, A. Murgo, A. Antognoli, L. Landuzzi, M. Fabbi, S. Ferrini, P. Musiani, M. Iezzi, C. De Giovanni & P.-L. Lollini: Antimetastatic activity of a preventive cancer vaccine. Cancer Res. 67: 11037-11044, 2007. IF: 7,656

N. Lazar, C. Manara, S. Navarro, A.M. Bleau, A. Lombart-Bosch, K. Scotlandi, N. Planque, B. Perbal: Doamin-specific CCN3 antibodies as unique tools for structural and functional studies. J. Cell Commun. Signal. 1: 91-102, 2007 IF: NO

2006

L. Pazzaglia, M.S. Benassi, P. Ragazzini, G. Gamberi, F. Ponticelli, A. Chiechi, C.M. Hattinger, L. Moranti, M. Alberghini, L. Zanella, P. Picci, M. Mercuri: Molecular alterations of monophasic synovial sarcoma: loss of chromosome 3p does not alter RASSF1 and MLH1 transciptional activity. Histol. Histopathol. 21: 187-195, 2006 IF: 2,023

K. Scotlandi, S. Perdichizzi, G. Bernard, G. Nicoletti, P. Nanni, P.-L. Lollini, A. Curti, M.C. Manara, S. Benini, A. Bernard, P. Picci: Targeting CD99 in association with doxorubicin: an effective combined treatment against Ewing’s sarcoma. Eur. J. Cancer 42: 91-96 2006. IF: 3,706

M.C. Manara, G. Bernard, P.-L. Lollini, P. Nanni, M. Zuntini, L. Landuzzi, S. Benini, G. Lattanzi, M. Sciandra, M. Serra, M.P. Colombo, A. Bernard, P. Picci, K. Scotlandi: CD99 acts as an oncosoppressor in osteosarcoma. Mol Biol. Cell 2006. IF: 6,526

G. Bacci, A. Longhi, M. Versari, M. Mercuri, A. Briccoli, P. Picci: Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Cancer 106: 1154-1161, 2006. IF: 4,800

R. Alleva, M.S. Benassi, L.Pazzaglia, M. Tomasetti, N. Gellert, B. Borghi, J. Neuzil, P. Picci: Alfa-tocopheryl succinate alters cell cycle distribution sensitising human osteosarcoma cells to methotrexate-induced apoptosis. Cancer Letters 232: 226-235, 2006. IF: 3,049

S. Boriani, S. Bandiera, R. Bigini, P. Bacchini, L. Boriani, M. Cappuccio, F. Chevalley, A. Gasbarrini, P. Picci, JN Weinstein: Chordoma of the mobile spine: fifty years of experience. Spine 31: 493-453, 2006 IF: 2,187

S. Benini, M. Zuntini, M.C. Manara, P. Cohen, G. Nicoletti, P. Nanni, Y. Oh, P. Picci, K. Scotlandi: Insulin-like growth factor binding protein 3 as an anticancer molecole in Ewing’s sarcoma. Int. J. Cancer 2006 IF: 4,700

G. Bacci, L. Loro, A. Longhi, F. Bertoni, P. Bacchini, M. Versari, P. Picci, M. Serra: No correlation between methotrexate serum level and histological response in the pre-operative treatment of extremity osteosarcoma. Anticancer Drugs 2006. IF: 1,907

G. Bacci, A. Longhi, A. Briccoli, F. Bertoni, M. Versari, P. Picci: The role of surgical margins in treatment of Ewing’s sarcoma family tumors: Experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy. Int. J. Radiation Oncology Biol. Phys. 2006. IF: 4,556

G. Bacci, A. Longhi, S. Ferrari, M. Mercuri, E. Barbieri, F. Bertoni, P. Bacchini, P. Picci: Pattern of relapse in 290 patients with nonmetastatic Ewing’s sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999. Eur J. Surg. Oncol. 2006. IF: 3,184

M. Tarkkanen, M.L. Larramendy, T. Bohling, M. Serra, C. Hattinger, A. Kivioja, I. Elomaa, P. Picci. S. Knuutila: Malignant fibrous histiocytoma of bone: Analysis of genomic imbalances by comparative genomic hybridization and C-MYC expression by immunohistochemistry. Eur. J. Cancer 42: 1172-1180, 2006 IF: 3,706

S. Frustaci, M. Berretta, A. Comandone, E. Bidoli, A. De Paoli, F. Gherlinzoni, T. De Pas, E. Barbieri, M. Pertici, G.Apice, P. Picci: Adjuvant treatment of high risk adult soft tissue sarcomas: a survey by the Italian Sarcoma Group. Tumori 92: 92-97, 2006 IF: 0,739

G. Bacci, N. Fabbri, A. Balladelli, C. Forni, E. Palmerini, P. Picci: Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients. J. Bone Joint Surg (Br) 88: 1071-1075, 2006 IF: 1,565

M. Dominkus, P. Ruggieri, F. Bertoni, A. Briccoli, P. Picci, M. Rocca, M. Mercuri: Histologically verified lung metastases in benign giant cell tumours – 14 cases from a single institution. Int. Orthop., 2006. IF: 0,676

M. Serra, M. Pasello, M.C. Manara, K. Scotlandi, S. Ferrari, F. Bertoni, M. Mercuri, T.A. Alvegard, P. Picci, G. Bacci, S. Smeland: May P-glycoprotien status be used to stratift high-grade osteosarcoma patients ? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol. Int. J. Oncol. 29: 1459-1468, 2006 IF: 2,681

G. Bacci, C. Ferrari, A. Longhi, S. Ferrari, C. Forni, P. Bacchini, E. Palmerini, A. Briccoli, E. Pienotti, A. Balladelli, P. Picci: Second malignant neoplasm in patients with osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy. J. Pediatr. Hematol. Oncol. 28: 774-780, 2006. IF: 1,282 4 punti

G. Bacci, A. Longhi, C. Forni, N. Fabbri, A. Briccoli, E. Barbieri, M. Mercuri, A. Balladelli, S. Ferrari, P. Picci: Neoadjuvant chemotherapy for radio induced osteosarcoma of the extremity: the Rizzoli experience in 20 cases. Int. J. Radiat. Oncol. Biol. Phys., 2006. I.F. 4,556.

M.S. Benassi, A. Chiechi, F. Ponticelli, L. Pazzaglia, G. Gamberi, L. Zanella, M.C. Manara, P. Perego, S. Ferrari, P. Picci: Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells. Cancer Lett. 2006. I.F. 3,049

P. Picci, K. Scotlandi, M. Serra, A. Rizzi: Prognostic and therapeutic tagets in the Ewing’s family of tumors (Prothets). Adv. Exp. Med. Biol. 587: 1-12, 2006 IF: 0,635

P. Tomba. A. Vigano, C. Menarini, P. Picci: From a 16th century monastery to a 21st century orthopaedic hospital. Brit. Med. J. 333: 1328-1330, 2006 IF: 9,052

G. Bacci, A. Longhi, F. Bertoni, A. Briccoli, M. Versari, E. Pignotti, P. Picci: Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy. The Rizzoli experience in 52 patients. Acta Orthop. 77: 938-943, 2006 IF: 1,157

A. Palladini, A. Astolfi, S. Croci, C. De Giovanni, G. Nicoletti, A. Rosolen, F. Sartori, P.-L. Lollini, L. Landuzzi, P. Nanni: Endothelin-3 production by human rhabdomyosarcoma: A possibile new marker with a paracrine role. Eur. J. Cancer 42: 680-687, 2006 IF: 3,706

B. Kubista, K. Trieb, F. Sevelda, C. Toma, F. Arrich, P. Heffeter, L. Elbling, H. Sutterluty, K. Scotlandi, R. Kotz, M. Micksche, W. Berger: Anticancer effect of zoledronic acid against human osteosarcoma cell lines. J. Orthop. Res. 24:1145-52, 2006. IF: 2,916

A. Strillacci, C. Grifoni, E. Spisni, M.C. Manara, V. Tomasi: RNA interference as a key to knockdown everexpressed ciclooxygenase-2 gene in tumour cells. Brit. J. Cancer, 94: 1300-1310, 2006 I.F: 4,115

Contenuto aggiornato il 02/11/2010 - 16:12
Redazione contenuti: Dott. Andrea Paltrinieri (redazioneweb@ior.it)
Utilizza SharethisShareThis  Scrivi una email  Vai a facebook  Vai a twitter